{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:48:12Z","timestamp":1782604092917,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jep.2024.118843","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:05:53Z","timestamp":1726725953000},"page":"118843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P2","title":["Efficacy and safety of SKCPT in patients with knee osteoarthritis: A multicenter, randomized, double-blinded, active-controlled phase III clinical trial"],"prefix":"10.1016","volume":"337","author":[{"given":"Sung II","family":"Bin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Baik","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Wan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Beom","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"In","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Bum","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Cheor","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ang","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Keun","family":"Seon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8871-8468","authenticated-orcid":false,"given":"Sang Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2024.118843_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/030097401316909602","article-title":"Symptoms modifying effect of avocado\/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study","volume":"30","author":"Appelboom","year":"2001","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jep.2024.118843_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/joca.2001.0471","article-title":"Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research","volume":"9","author":"Bae","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jep.2024.118843_bib3","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jep.2024.118843_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/rheumatology\/kel296","article-title":"Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies","volume":"46","author":"Bingham III","year":"2007","journal-title":"Rheumatology"},{"issue":"18","key":"10.1016\/j.jep.2024.118843_bib5","article-title":"Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing","volume":"97","author":"Chi","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jep.2024.118843_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4078\/jrd.2019.26.3.179","article-title":"Nonsteroidal anti-inflammatory drugs-sparing effect of symptomatic slow-acting drugs for osteoarthritis in knee osteoarthritis patients","volume":"26","author":"Cho","year":"2019","journal-title":"J. Rheum. Dis."},{"key":"10.1016\/j.jep.2024.118843_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3904\/kjim.2014.29.5.647","article-title":"SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes","volume":"29","author":"Choi","year":"2014","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.jep.2024.118843_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2024.118843_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.joca.2015.05.016","article-title":"Metabolic stress-induced joint inflammation and osteoarthritis","volume":"23","author":"Courties","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jep.2024.118843_bib10","doi-asserted-by":"crossref","first-page":"n2321","DOI":"10.1136\/bmj.n2321","article-title":"Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis","volume":"375","author":"da Costa","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jep.2024.118843_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jbspin.2006.09.008","article-title":"Symptomatic slow-acting drugs for osteoarthritis: what are the facts?","volume":"73","author":"Dougados","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jep.2024.118843_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phymed.2007.09.005","article-title":"The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators","volume":"15","author":"Hartog","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2024.118843_bib13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2011.580340","article-title":"Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials","volume":"27","author":"Hochberg","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jep.2024.118843_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(20)32230-3","article-title":"Osteoarthritis in 2020 and beyond: a lancet commission","volume":"396","author":"Hunter","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2024.118843_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4062\/biomolther.2019.139","article-title":"Natural products as sources of novel drug candidates for the pharmacological management of osteoarthritis: a narrative review","volume":"27","author":"Kang","year":"2019","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.jep.2024.118843_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3346\/jkms.2010.25.2.293","article-title":"The prevalence of knee osteoarthritis in elderly community residents in Korea","volume":"25","author":"Kim","year":"2010","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.jep.2024.118843_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1254\/jphs.FPJ04058X","article-title":"SKI306X suppresses cartilage destruction and inhibits the production of matrix metalloproteinase in rabbit joint cartilage explant culture","volume":"98","author":"Kim","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jep.2024.118843_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5792\/ksrr.17.004","article-title":"Efficacy of JOINS on cartilage protection in knee osteoarthritis: prospective randomized controlled trial","volume":"29","author":"Kim","year":"2017","journal-title":"Knee Surg. Relat. Res."},{"key":"10.1016\/j.jep.2024.118843_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jep.2024.118843_bib20","article-title":"Oleanolic acid improves obesity-related inflammation and insulin resistance by regulating macrophages activation","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2024.118843_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.joca.2007.02.021","article-title":"The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study","volume":"15","author":"Louthrenoo","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jep.2024.118843_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphar.2020.00153","article-title":"A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2024.118843_bib23","unstructured":"Ministry of Food and Drug Safety. Available at: https:\/\/www.mfds.go.kr\/eng\/index.do (accessed 21 March 2024)."},{"key":"10.1016\/j.jep.2024.118843_bib25","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2024.118843_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.berh.2018.10.007","article-title":"Update on the epidemiology, risk factors and disease outcomes of osteoarthritis","volume":"32","author":"O'Neill","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jep.2024.118843_bib27","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jep.2024.118843_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3904\/kjim.2017.304","article-title":"Treatment patterns of knee osteoarthritis patients in Korea","volume":"34","author":"Park","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.jep.2024.118843_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jep.2013.08.008","article-title":"A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint","volume":"149","author":"Park","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2024.118843_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/ph14030205","article-title":"Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies' guidelines","volume":"14","author":"Primorac","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jep.2024.118843_bib31","article-title":"Celecoxib for osteoarthritis","volume":"5","author":"Puljak","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jep.2024.118843_bib32","author":"Roser"},{"key":"10.1016\/j.jep.2024.118843_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","article-title":"Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study","volume":"79","author":"Safiri","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jep.2024.118843_bib34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1185\/030079906X104876","article-title":"Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies","volume":"22","author":"Smugar","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jep.2024.118843_bib35","doi-asserted-by":"crossref","first-page":"448.e27","DOI":"10.1016\/j.amjmed.2005.11.020","article-title":"Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis","volume":"119","author":"Spiegel","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jep.2024.118843_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7861\/clinmed.2021-0039","article-title":"Non-steroidal anti-inflammatory drugs and the gastrointestinal tract","volume":"21","author":"Tai","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.jep.2024.118843_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/rheumatology\/ket346","article-title":"Defining and mapping the person with osteoarthritis for population studies and public health","volume":"53","author":"Thomas","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.jep.2024.118843_bib38","article-title":"Tramadol for osteoarthritis","volume":"5","author":"Toupin April","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jep.2024.118843_bib39","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jep.2024.118843_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110568","article-title":"Ursolic acid protects chondrocytes, exhibits anti-inflammatory properties via regulation of the NF-\u03baB\/NLRP3 inflammasome pathway and ameliorates osteoarthritis","volume":"130","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2024.118843_bib41","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/nm.2543","article-title":"Identification of a central role for complement in osteoarthritis","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2024.118843_bib42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12891-018-1999-5","article-title":"Risk factors for progression of radiographic knee osteoarthritis in elderly community residents in Korea","volume":"19","author":"Yoo","year":"2018","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.jep.2024.118843_bib43","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1185\/03007995.2014.955169","article-title":"Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial","volume":"30","author":"Yoo","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jep.2024.118843_bib44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00296-014-2964-8","article-title":"Efficacy and safety of PG201 (Layla(\u00ae)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study","volume":"34","author":"Yoo","year":"2014","journal-title":"Rheumatol. Int."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124011425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124011425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:41:04Z","timestamp":1731469264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874124011425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S0378874124011425"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2024.118843","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of SKCPT in patients with knee osteoarthritis: A multicenter, randomized, double-blinded, active-controlled phase III clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2024.118843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118843"}}